Stargardt Macular Dystrophy
7 clinical trials · Condition
◉ Watch Stargardt Macular Dystrophy
| Record | Firm | Date |
|---|---|---|
| Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE) (NCT04239625) | Alkeus Pharmaceuticals, Inc. | 2019-12-20 |
| Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (NCT02402660) | Alkeus Pharmaceuticals, Inc. | 2015-08-01 |
Track Stargardt Macular Dystrophy automatically
Every clearance here is in the API, with alerts when new ones post.